Marksans Pharma to Hold Board Meeting to Approve Qended June 30 Unaudited Results
Marksans Pharma Ltd has scheduled a meeting of its Board of Directors to review and approve the company's Unaudited Financial Results for the Quarter ended June 30, 2026.The Board meeting is set to take place on Wednesday, August 12, 2026, in Mumbai. The primary agenda item for the meeting will be the consideration and approval of the Unaudited Financial Results, covering both Standalone and Consolidated figures for the specified quarter.
In line with regulations concerning insider trading, Marksans Pharma Ltd has mandated specific restrictions regarding the trading window for Designated Persons (including Directors) and their immediate relatives. The trading window was closed starting July 1, 2026, and it will remain closed until Forty-Eight hours following the announcement of the Financial Results, which extends up to August 14, 2026 (both days inclusive).
MARKSANS Stock Price Movement
Shares of Marksans Pharma Limited are edging higher to ₹259.00 as of 1:01 PM today, climbing by 0.15% on the live market floor. The stock navigates a volatile intraday range, trading between a low of ₹252.05 and a high of ₹262.4 amid activity totaling 500,282 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.